A drug used to
treat non-small cell lung cancer and urothelial cancer (a
type of bladder cancer) that have advanced or spread to
other parts of the body. It is used in patients whose
disease got worse during or after treatment with anticancer
drugs that included platinum. It is also being studied in
the treatment of other types of cancer.
Atezolizumab binds to a protein
called PD-L1, which is found on some cancer cells.
Atezolizumab may block this protein
and help the immune system kill cancer cells. It is a type
of monoclonal antibody and a type of immune checkpoint
inhibitor. Also called Tecentriq.